Cargando…
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study
INTRODUCTION: Antiretroviral therapy has improved the life expectancy of patients living with HIV. However, lipodystrophy syndrome (LD) remains prevalent, affecting mostly patients treated with first-generation antiretroviral drugs. This syndrome is characterized by changes in body fat distribution...
Autores principales: | Bouatou, Yassine, Gayet Ageron, Angele, Bernasconi, Enos, Battegay, Manuel, Hoffmann, Matthias, Staehelin, Cornelia, Merz, Laurent, Kovari, Helen, Fux, Christoph, de Seigneux, Sophie, Calmy, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127405/ https://www.ncbi.nlm.nih.gov/pubmed/30197975 http://dx.doi.org/10.1016/j.ekir.2018.04.014 |
Ejemplares similares
-
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
por: Sculier, Delphine, et al.
Publicado: (2017) -
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
por: Gueler, Aysel, et al.
Publicado: (2017) -
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study
por: Young, Jim, et al.
Publicado: (2015) -
Clinicians’ views regarding caesarean section rates in Switzerland: A cross-sectional web-based survey
por: Mauri, Fabio, et al.
Publicado: (2023) -
Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders
por: Verolet, Charlotte M, et al.
Publicado: (2015)